
Inhye Ahn,MD
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
The overarching goals of my research are to uncover molecular mechanisms of treatment resistance and develop innovative therapies and individualized care for patients with chronic lymphocytic leukemia (CLL). To achieve these aims, I am leading clinical trials testing early intervention strategies in high-risk CLL and novel combination regimens in drug-resistant disease.

Inhye Ahn,MD
Dana-Farber Cancer Institute